Partnership advances targeted therapies for blood cancers
Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with a clinical trial specifically designed for the genetic signature of their disease. Sponsored by the National Cancer Institute (NCI), the myeloMATCH program aims to improve precision medicine, the use of therapies ...
















